Solara Active Pharma Sciences - PP Share Price Today | Stock Price & Solara Active Pharma Sciences - PP Share Screener
As of March 30, 2026, the live Solara Active Pharma Sciences - PP share price (BSE: SOLARAPP1) is ₹273.50, down 10.27% from the previous close, with shares trading between ₹272.20 and ₹281.00 in today's trading session, and a 52-week range of ₹270.00–₹440.10. Check SOLARAPP1 52-week performance for the annual price range and momentum. Use the Solara Active Pharma Sciences - PP stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Solara Active Pharma Sciences - PP opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Solara Active Pharma Sciences - PP Share Price Chart
Track the current stock price of Solara Active Pharma Sciences - PP with an interactive chart. Analyse SOLARAPP1 share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Solara Active Pharma Sciences - PP stock quote in one place.
The quote of ₹273.50 sits between the 52-week low of ₹270.00 and the 52-week high of ₹440.10, and the latest session moved -10.27% from the previous close.
Solara Active Pharma Sciences - PP Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences - PP company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SOLARAPP1 shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN IN9624Z01022.
Company Details
Classification
Identifiers and Leadership
Solara Active Pharma Sciences - PP Balance Sheet Screener
Screen SOLARAPP1 balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
Solara Active Pharma Sciences - PP Income Statement Screener - Profit & Revenue Analysis
Screen Solara Active Pharma Sciences - PP income statement and profit fundamentals. Analyze SOLARAPP1 quarterly results. Solara Active Pharma Sciences - PP reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
Solara Active Pharma Sciences - PP Cash Flow Screener - Liquidity Fundamentals
Screen SOLARAPP1 cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
Solara Active Pharma Sciences - PP Shareholding Pattern Screener
See Solara Active Pharma Sciences - PP shareholding pattern with promoter, FII, and DII holdings. Check Solara Active Pharma Sciences - PP promoter holding and ownership changes for SOLARAPP1 on TickJournal, and see how institutional stock price moves affect the market.
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Solara Active Pharma Sciences - PP. Solara Active Pharma Sciences - PP dividend yield can be compared with peers and other stocks in the market.
Solara Active Pharma Sciences - PP Stock Index Membership - Nifty & Sensex
See which indices include Solara Active Pharma Sciences - PP stock. Check SOLARAPP1 index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Solara Active Pharma Sciences - PP Market Events Screener - Corporate Actions
Get Solara Active Pharma Sciences - PP corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Solara Active Pharma Sciences - PP stock events that may affect SOLARAPP1 share price, along with derivatives, futures and options activity and sector gainers.
1 corporate actions are listed, the most recent entry being Annual General Meeting dated .
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 6.67% |
Solara Active Pharma Sciences - PP Competitors Screener - Peer Stocks Comparison
Screen SOLARAPP1 competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,345 | 39.32 | 54,729 | 9.71% | 10,980 | 56.35 |
| Divis Laboratories | 159,215 | 64.39 | 9,712 | 18.67% | 2,191 | 39.57 |
| Torrent Pharmaceuticals | 144,367 | 64.00 | 11,539 | 6.99% | 1,911 | 49.85 |
| Dr Reddys Laboratories | 106,975 | 19.68 | 33,741 | 16.73% | 5,725 | 49.71 |
| Lupin | 106,653 | 22.98 | 22,910 | 13.74% | 3,306 | 56.95 |
| Cipla | 100,349 | 22.17 | 28,410 | 7.12% | 5,291 | 34.82 |
| Zydus Life Science | 90,229 | 18.09 | 23,511 | 18.55% | 4,615 | 49.23 |
| Mankind Pharma | 84,163 | 46.25 | 12,744 | 20.90% | 2,007 | 44.70 |
| Aurobindo Pharma | 76,329 | 21.80 | 32,346 | 9.43% | 3,484 | 63.55 |
| Alkem Laboratories | 63,902 | 26.83 | 13,458 | 3.70% | 2,216 | 45.83 |
Solara Active Pharma Sciences - PP Company Announcements - News & Reports Screener
Screen SOLARAPP1 latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated October 4, 2026 and October 4, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Closure of Trading Window | - |
| 2026-10-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-10-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-10-03 | General Update - Rights Issue - Second & Final Call | - |
| 2026-10-03 | Corporate Action- Record Date For The Purpose Of Making Second And Final Call For Rights Equity Shares | - |
| 2026-09-27 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-10 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-03-10 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-03-04 | Receipt Of Call Money Pursuant To The Second Reminder Notice Issued For Payment Of First Call Money On Rights Shares | - |
| 2026-03-04 | Intimation Regarding The Closure Of Wholly Owned Subsidiary Of The Company In Brazil. | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025. | - |
| 2026-02-06 | Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies. | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-06 | Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025 | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹273.50, within a 52-week range of ₹270.00 to ₹440.10. The P/B ratio is 2.29. Market capitalisation stands at ₹346.36 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Information is provided for research and is not investment advice.